#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma malignant Retinal artery occlusion Acute myeloid leukaemia Focal segmental glomerulosclerosis Neuroendocrine cell hyperplasia of infancy Dementia Thromboangiitis obliterans Sarcoidosis Arterial tortuosity syndrome T-cell type acute leukaemia Acute leukaemia Glomerulonephritis rapidly progressive Mantle cell lymphoma stage II Barth syndrome X-linked lymphoproliferative syndrome More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Trials in Disease Hereditary optic atrophy – Treatment Angiosarcoma metastatic Castleman’s disease – Life with Disease Wiskott-Aldrich syndrome Combined immunodeficiency Myxofibrosarcoma – Basic Information Cholangitis sclerosing Breast angiosarcoma metastatic – Basic Information Congenital generalised lipodystrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dextromethadone Hydrochloride Incb000928 Zolbetuximab Lecanemab Pelareorep BI-1607 HYDROXYCHLOROQUINE Hydroxychloroquine Sulfate Enalapril Maleate Dsimc Lolium Perenne Streptococcus Agalactiae Poa Pratensis ALENDRONATE SODIUM TRIHYDRATE Sqy51 Zinc Sulphate Heptahydrate Antiemetics And Antinauseants Serpina1(Human)-Aav8-1 Glenzocimab Rilpivirine More therapies…

    Learn about Your Condition

    Haemoptysis Cardiac amyloidosis Hypoalbuminaemia Acute myeloid leukaemia Arrhythmia supraventricular Castleman's disease Chronic hepatitis C Albright's disease Patent ductus arteriosus Knee arthroplasty Post procedural swelling Cushing's syndrome Procedural pain Osteosarcoma recurrent Thalassaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer limited stage

  • Study of Tarlatamab maintenance treatment after chemotherapy and radiation therapy in patients with limited stage small cell lung cancer who cannot receive both treatments together

    Recruiting

    2 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Tarlatamab
    Spain

  • Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

    Recruiting

    3 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • TIFCEMALIMAB
    • Toripalimab
    Belgium France Germany Italy The Netherlands Poland +2

  • Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Durvalumab
    Denmark Finland Lithuania The Netherlands Norway

  • Study on the Effectiveness and Safety of Cisplatin, Carboplatin, Etoposide, and Durvalumab in Patients with Limited Stage Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    Germany

  • Durvalumab Maintenance Therapy for Frail Patients with Limited Stage Small Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    France

  • Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Argipressin
    • Betamethasone Sodium Phosphate
    • Mannitol
    Austria Belgium Bulgaria France Germany Greece +6
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!